Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

CRMD, CELC, RANI, and RAPT are pushing aggressively to the upside on Monday. Here's what is driving these four biotech stocks ...

Not just any pharmaceutical stock will do, though. They aren't all created equal. Let's discuss two leaders in the industry ...

These companies are investing heavily into their pipelines and the payoff for long-term investors can be substantial.

Summit Therapeutics Inc. (NASDAQ: SMMT) is one of the best biotech stocks with high potential. In a report released on ...

Pfizer ( PFE) is number one and the leader in my list of "top 3 Big Pharma stocks." Over the last three quarters I have seen ...

​This partnership builds on an earlier collaboration, which was launched between the two companies in 2022. As part of this ...

Many of the biotech stocks remain outside of Mr. Market's interest zone. Check out five biotech firms that may be of interest ...

PfizerPFE stock surged Wednesday, pulling shares of AstraZenecaAZN, GSKGSK and NovartisNVS higher, after the Dow Jones component struck a deal with the Trump administration to avoid a 100% ...

Cohen's Point72 purchased over 8 million shares of C4 Therapeutics within weeks of the company announcing phase 1 trial data ...

Rani Therapeutics Holdings ($RANI), a clinical-stage penny biotech stock, soared nearly 250% on Friday and continued to trade ...